Kaiser Permanente Center for Health Research, Portland, OR.
Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA.
Vaccine. 2022 Jan 31;40(5):752-756. doi: 10.1016/j.vaccine.2021.12.048. Epub 2021 Dec 31.
The Vaccine Safety Datalink (VSD) uses vaccination data from electronic health records (EHR) at eight integrated health systems to monitor vaccine safety. Accurate capture of data from vaccines administered outside of the health system is critical for vaccine safety research, especially for COVID-19 vaccines, where many are administered in non-traditional settings. However, timely access and inclusion of data from Immunization Information Systems (IIS) into VSD safety assessments is not well understood.
We surveyed the eight data-contributing VSD sites to assess: 1) status of sending data to IIS; 2) status of receiving data from IIS; and 3) integration of IIS data into the site EHR. Sites reported separately for COVID-19 vaccination to capture any differences in capacity to receive and integrate data on COVID-19 vaccines versus other vaccines.
All VSD sites send data to and receive data from their state IIS. All eight sites (100%) routinely integrate IIS data for COVID-19 vaccines into VSD research studies. Six sites (75%) also routinely integrate all other vaccination data; two sites integrate data from IIS following a reconciliation process, which can result in delays to integration into VSD datasets.
COVID-19 vaccines are being administered in a variety of non-traditional settings, where IIS are commonly used as centralized reporting systems. All eight VSD sites receive and integrate COVID-19 vaccine data from IIS, which positions the VSD well for conducting quality assessments of vaccine safety. Efforts to improve the timely receipt of all vaccination data will improve capacity to conduct vaccine safety assessments within the VSD.
疫苗安全数据链(VSD)利用八个综合健康系统的电子健康记录(EHR)中的接种数据来监测疫苗安全性。准确捕捉在健康系统之外接种的疫苗数据对于疫苗安全性研究至关重要,尤其是对于 COVID-19 疫苗,因为这些疫苗通常在非传统场所接种。然而,及时访问和将免疫信息系统(IIS)中的数据纳入 VSD 安全评估对于该系统来说并不清楚。
我们调查了八个提供数据的 VSD 站点,以评估:1)向 IIS 发送数据的情况;2)从 IIS 接收数据的情况;3)将 IIS 数据整合到站点 EHR 中的情况。各站点分别报告 COVID-19 疫苗接种情况,以了解接收和整合 COVID-19 疫苗数据与其他疫苗数据的能力差异。
所有 VSD 站点都向其州 IIS 发送数据并从其接收数据。所有八个站点(100%)都例行将 COVID-19 疫苗的 IIS 数据常规整合到 VSD 研究中。六个站点(75%)还例行整合来自 IIS 的所有其他疫苗接种数据;两个站点会在数据整合到 VSD 数据集之前,通过数据核对过程来整合来自 IIS 的数据,这可能会导致数据整合延迟。
COVID-19 疫苗正在各种非传统场所接种,IIS 通常用作集中报告系统。所有八个 VSD 站点都从 IIS 接收和整合 COVID-19 疫苗数据,这使 VSD 能够很好地进行疫苗安全性质量评估。为了提高及时接收所有疫苗接种数据的能力,需要改进措施,以提高在 VSD 中进行疫苗安全性评估的能力。